Shionogi Eyes More US Plants, M&A Deals Shionogi, a Japanese pharmaceutical company, has been rapidly expanding in the US market with new plants and mergers and acquisitions (M&A) deals.
The expansion is part of its broader strategy to increase global reach and establish itself as a major player in the industry.
Context of Shionogi's US Plant Expansion Shionogi has been investing in the US for several years, focusing on developing and manufacturing pharmaceuticals specifically for the American market.